Metabolic Disease
News on research and diagnostics for metabolic disorders and metabolic diseases.
TruDiagnostic, Nadmed Partner to Launch Nadmed Metabolite Test in US
The blood-based test measures NAD+ and NADH metabolites linked with diseases affecting immune function, metabolic disease, and neurodegeneration.
DxGen, Precision Diabetes Partner on Point-of-Care Analyzer
The test menu for DxGen's Epithod AutoDx includes assays for hemoglobin A1C, C-reactive protein, and urinary albumin assays, with more tests planned for the near future.
PreventionGenetics Nabs FDA Approval for Obesity Drug Companion Diagnostic
The test detects variants in the POMC, PCSK1, and LEPR genes to identify individuals eligible for treatment with Rhythm Pharmaceuticals' recently approved Imcivree.
MultiOmic Health, Mesh Bio Partner to Study Chronic Metabolic Disease for Drug, Dx Development
The companies will build a diverse research cohort with multiomics data and apply AI as they seek to improve diagnostics and advance drug discovery.
Finnish Startup Nadmed Nabs CE-IVD Mark for Q-Nadmed Kit
The test is used for analyzing oxidized and reduced types of NAD metabolites, NAD+ and NADH.